Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Acumen Pharmaceuticals (NASDAQ:ABOS) through any online brokerage.
Other companies in Acumen Pharmaceuticals’s space includes: Anixa Biosciences Inc (NASDAQ:ANIX), Fortress Biotech Inc (NASDAQ:FBIO), Connect Biopharma Holdings Ltd (NASDAQ:CNTB), Elicio Therapeutics Inc (NASDAQ:ELTX) and Fate Therapeutics Inc (NASDAQ:FATE).
Acumen Pharmaceuticals has a consensus price target of $8.50.
The stock price for Acumen Pharmaceuticals (NASDAQ: ABOS) is $2.0206 last updated December 18, 2025 at 10:32 AM EST.
There are no upcoming dividends for Acumen Pharmaceuticals.
Acumen Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Acumen Pharmaceuticals.
Acumen Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.